News
908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook
908 Devices Advances MX908 Handheld Device Capabilities
908 Devices Partners with Key Biomanufacturing Innovation Center
908 Devices and CPI Team on Cell Culture Media Optimization for Improved Process Control in Bioprocessing Applications
908 Devices to Report First Quarter Financial Results on May 10, 2022
908 Devices Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Revenue Outlook
908 Devices Appoints Tony J. Hunt, President and CEO, Repligen, to its Board of DirectorsÂ
908 Devices to Report Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022
908 Devices to Participate in Upcoming Investor Conferences – Q1 2022
908 Devices Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021
908 Devices Announces GSK Purchases Fifth REBEL Cell Culture Media Analyzer
908 Devices and U.S. Forest Service Announce Development Collaboration
Subscribe to Our Communications
Signup to receive new product updates, technical tips and more.